Early exposure to environmental enrichment alters the expression of genes of the endocannabinoid system

Brain Research

Volumn 1390, Issue , 2011, Pages 80-89

  El Rawas, Rana ^a   Thiriet, Nathalie ^a   Nader, Joëlle ^a   Lardeux, Virginie ^a   Jaber, Mohamed ^a   Solinas, Marcello ^a  

^a UNIVERSITÉ DE POITIERS   (France)

Author keywords

Cannabinoid; Drug addiction; Fatty acid amide hydrolase; In situ hybridization; Monoacylglycerol lipase; Stress

Indexed keywords

ACYLGLYCEROL LIPASE; CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; FATTY ACID AMIDASE; MESSENGER RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BASOLATERAL AMYGDALA; BRAIN REGION; DRUG DEPENDENCE; DRUG EXPOSURE; ENVIRONMENTAL ENRICHMENT; GENE EXPRESSION; HYPOTHALAMUS; IN SITU HYBRIDIZATION; MALE; MEDIAL AMYGDALA; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AGE FACTORS; AMIDOHYDROLASES; ANIMALS; BEHAVIOR, ADDICTIVE; ENDOCANNABINOIDS; ENVIRONMENT; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; MICE, INBRED C57BL; MONOACYLGLYCEROL LIPASES; RANDOM ALLOCATION; RECEPTOR, CANNABINOID, CB1; RNA, MESSENGER;

MUS;

EID: 79955623474     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2011.03.025     Document Type: Article

References (78)

1. Bardo, M.T., Klebaur, J.E., Valone, J.M., Deaton, C., 2001. Environmental enrichment decreases intravenous self-administration of amphetamine in female and male rats. Psychopharmacol. (Berl) 155, 278-284.
2. Belz, E.E., Kennell, J.S., Czambel, R.K., Rubin, R.T., Rhodes, M.E., 2003. Environmental enrichment lowers stress-responsive hormones in singly housed male and female rats. Pharmacol. Biochem. Behav. 76, 481-486.
3. Benaroya-Milshtein, N., Hollander, N., Apter, A., Kukulansky, T., Raz, N., Wilf, A., Yaniv, I., Pick, C.G., 2004. Environmental enrichment in mice decreases anxiety, attenuates stress responses and enhances natural killer cell activity. Eur. J. Neurosci. 20, 1341-1347.
4. Bezard, E., Dovero, S., Belin, D., Duconger, S., Jackson-Lewis, V., Przedborski, S., Piazza, P.V., Gross, C.E., Jaber, M., 2003. Enriched environment confers resistance to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and cocaine: involvement of dopamine transporter and trophic factors. J. Neurosci. 23, 10999-11007.
5. Caille, S., Alvarez-Jaimes, L., Polis, I., Stouffer, D.G., Parsons, L.H., 2007. Specific alterations of extracellular endocannabinoid levels in the nucleus accumbens by ethanol, heroin, and cocaine self-administration. J. Neurosci. 27, 3695-3702. (Pubitemid 46557675)
6. Carroll, M.E., Anker, J.J., Perry, J.L., 2009. Modeling risk factors for nicotine and other drug abuse in the preclinical laboratory. Drug Alcohol Depend. 104 (Suppl 1), S70-S78.
7. Cota, D., 2008. The role of the endocannabinoid system in the regulation of hypothalamic-pituitary-adrenal axis activity. J. Neuroendocrinol. 20 (Suppl 1), 35-38. (Pubitemid 351552674)
8. Cravatt, B.F., Lichtman, A.H., 2003. Fatty acid amide hydrolase: an emerging therapeutic target in the endocannabinoid system. Curr. Opin. Chem. Biol. 7, 469-475.
9. Di Marzo, V., Bifulco, M., De Petrocellis, L., 2004. The endocannabinoid system and its therapeutic exploitation. Nat. Rev. Drug Discov. 3, 771-784.
10. Di, S., Malcher-Lopes, R., Halmos, K.C., Tasker, J.G., 2003. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J. Neurosci. 23, 4850-4857. (Pubitemid 36793211)
11. Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, S.L., Kathuria, S., Piomelli, D., 2002. Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc. Natl Acad. Sci. U.S.A. 99, 10819-10824.
12. El Rawas, R., Thiriet, N., Lardeux, V., Jaber, M., Solinas, M., 2009. Environmental enrichment decreases the rewarding but not the activating effects of heroin. Psychopharmacol. (Berl) 203, 561-570.
13. Freund, T.F., Katona, I., Piomelli, D., 2003. Role of endogenous cannabinoids in synaptic signaling. Physiol. Rev. 83, 1017-1066.
14. Ganon-Elazar, E., Akirav, I., 2009. Cannabinoid receptor activation in the basolateral amygdala blocks the effects of stress on the conditioning and extinction of inhibitory avoidance. J. Neurosci. 29, 11078-11088.
15. Gardner, E.L., 2005. Endocannabinoid signaling system and brain reward: emphasis on dopamine. Pharmacol. Biochem. Behav. 81, 263-284.
16. Giuffrida, A., Parsons, L.H., Kerr, T.M., Rodriguez de Fonseca, F., Navarro, M., Piomelli, D., 1999. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum. Nat. Neurosci. 2, 358-363.
17. Glass, M., van Dellen, A., Blakemore, C., Hannan, A.J., Faull, R.L., 2004. Delayed onset of Huntington's disease in mice in an enriched environment correlates with delayed loss of cannabinoid CB1 receptors. Neuroscience 123, 207-212. (Pubitemid 37518488)
18. Goeders, N.E., 2002. Stress and cocaine addiction. J. Pharmacol. Exp. Ther. 301, 785-789.
19. Gorzalka, B.B., Hill, M.N., Hillard, C.J., 2008. Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci. Biobehav. Rev. 32, 1152-1160.
20. Green, T.A., Gehrke, B.J., Bardo, M.T., 2002. Environmental enrichment decreases intravenous amphetamine self-administration in rats: dose-response functions for fixed- and progressive-ratio schedules. Psychopharmacol. (Berl) 162, 373-378.
21. Green, T.A., Alibhai, I.N., Roybal, C.N., Winstanley, C.A., Theobald, D.E., Birnbaum, S.G., Graham, A.R., Unterberg, S., Graham, D.L., Vialou, V., Bass, C.E., Terwilliger, E.F., Bardo, M.T., Nestler, E.J., 2010. Environmental enrichment produces a behavioral phenotype mediated by low cyclic adenosine monophosphate response element binding (CREB) activity in the nucleus accumbens. Biol. Psychiatry 67, 28-35.
22. Hall, F.S., 1998. Social deprivation of neonatal, adolescent, and adult rats has distinct neurochemical and behavioral consequences. Crit. Rev. Neurobiol. 12, 129-162.
23. Herkenham, M., Lynn, A.B., Little, M.D., Johnson, M.R., Melvin, L.S., de Costa, B.R., Rice, K.C., 1990. Cannabinoid receptor localization in brain. Proc. Natl Acad. Sci. U.S.A. 87, 1932-1936.
24. Hill, M.N., Carrier, E.J., McLaughlin, R.J., Morrish, A.C., Meier, S.E., Hillard, C.J., Gorzalka, B.B., 2008. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J. Neurochem. 106, 2322-2336.
25. Hill, M.N., Gorzalka, B.B., 2009. The endocannabinoid system and the treatment of mood and anxiety disorders. CNS Neurol. Disord. Drug Targets 8, 451-458.
26. Hill, M.N., McEwen, B.S., 2009. Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids. Prog. Neuropsychopharmacol. Biol. Psychiatry.
27. Hill, M.N., McLaughlin, R.J., Morrish, A.C., Viau, V., Floresco, S.B., Hillard, C.J., Gorzalka, B.B., 2009. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary- adrenal axis. Neuropsychopharmacology 34, 2733-2745.
28. Hill, M.N., Patel, S., Campolongo, P., Tasker, J.G., Wotjak, C.T., Bains, J.S., 2010. Functional interactions between stress and the endocannabinoid system: from synaptic signaling to behavioral output. J. Neurosci. 30, 14980-14986.
29. Howlett, A.C., Breivogel, C.S., Childers, S.R., Deadwyler, S.A., Hampson, R.E., Porrino, L.J., 2004. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 (Suppl 1), 345-358. (Pubitemid 39298276)
30. Justinova, Z., Goldberg, S.R., Heishman, S.J., Tanda, G., 2005. Self-administration of cannabinoids by experimental animals and human marijuana smokers. Pharmacol. Biochem. Behav. 81, 285-299.
31. Kofalvi, A., Rodrigues, R.J., Ledent, C., Mackie, K., Vizi, E.S., Cunha, R.A., Sperlagh, B., 2005. Involvement of cannabinoid receptors in the regulation of neurotransmitter release in the rodent striatum: a combined immunochemical and pharmacological analysis. J. Neurosci. 25, 2874-2884. (Pubitemid 40389245)
32. Kreek, M.J., Nielsen, D.A., Butelman, E.R., LaForge, K.S., 2005. Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction. Nat. Neurosci. 8, 1450-1457.
33. Laviola, G., Rea, M., Morley-Fletcher, S., Di Carlo, S., Bacosi, A., De Simone, R., Bertini, M., Pacifici, R., 2004. Beneficial effects of enriched environment on adolescent rats from stressed pregnancies. Eur. J. Neurosci. 20, 1655-1664.
34. Laviola, G., Hannan, A.J., Macri, S., Solinas, M., Jaber, M., 2008. Effects of enriched environment on animal models of neurodegenerative diseases and psychiatric disorders. Neurobiol. Dis. 31, 159-168.
35. Ledent, C., Valverde, O., Cossu, G., Petitet, F., Aubert, J.F., Beslot, F., Bohme, G.A., Imperato, A., Pedrazzini, T., Roques, B.P., Vassart, G., Fratta, W., Parmentier, M., 1999. Unresponsiveness to cannabinoids and reduced addictive effects of opiates in CB1 receptor knockout mice. Science 283, 401-404.
36. Malone, D.T., Kearn, C.S., Chongue, L., Mackie, K., Taylor, D.A., 2008. Effect of social isolation on CB1 and D2 receptor and fatty acid amide hydrolase expression in rats. Neuroscience 152, 265-272.
37. Marinelli, M., Piazza, P.V., 2002. Interaction between glucocorticoid hormones, stress and psychostimulant drugs. Eur. J. Neurosci. 16, 387-394.
38. Marsicano, G., Lutz, B., 1999. Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci. 11, 4213-4225.
39. McEwen, B.S., 2007. Physiology and neurobiology of stress and adaptation: central role of the brain. Physiol. Rev. 87, 873-904.
40. Moncek, F., Duncko, R., Johansson, B.B., Jezova, D., 2004. Effect of environmental enrichment on stress related systems in rats. J. Neuroendocrinol. 16, 423-431. (Pubitemid 38744836)
41. Morley-Fletcher, S., Rea, M., Maccari, S., Laviola, G., 2003. Environmental enrichment during adolescence reverses the effects of prenatal stress on play behaviour and HPA axis reactivity in rats. Eur. J. Neurosci. 18, 3367-3374.
42. Nithianantharajah, J., Hannan, A.J., 2006. Enriched environments, experience-dependent plasticity and disorders of the nervous system. Nat. Rev. Neurosci. 7, 697-709.
43. Patel, S., Roelke, C.T., Rademacher, D.J., Cullinan, W.E., Hillard, C.J., 2004. Endocannabinoid signaling negatively modulates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Endocrinology 145, 5431-5438. (Pubitemid 39564580)
44. Piomelli, D., 2003. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci. 4, 873-884.
45. Robinson, S.A., Loiacono, R.E., Christopoulos, A., Sexton, P.M., Malone, D.T., 2010. The effect of social isolation on rat brain expression of genes associated with endocannabinoid signaling. Brain Res. 1343, 153-167.
46. Rodriguez, J.J., Mackie, K., Pickel, V.M., 2001. Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus. J. Neurosci. 21, 823-833. (Pubitemid 32163123)
47. Rubino, T., Patrini, G., Massi, P., Fuzio, D., Vigano, D., Giagnoni, G., Parolaro, D., 1998. Cannabinoid-precipitated withdrawal: a time-course study of the behavioral aspect and its correlation with cannabinoid receptors and G protein expression. J. Pharmacol. Exp. Ther. 285, 813-819.
48. Rubino, T., Vigano, D., Costa, B., Colleoni, M., Parolaro, D., 2000a. Loss of cannabinoid-stimulated guanosine 5′-O-(3-[(35)S]Thiotriphosphate) binding without receptor down-regulation in brain regions of anandamide-tolerant rats. J. Neurochem. 75, 2478-2484.
49. Rubino, T., Vigano, D., Massi, P., Parolaro, D., 2000b. Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940. J. Neurochem. 75, 2080-2086.
50. Rubino, T., Vigano, D., Massi, P., Parolaro, D., 2003. Cellular mechanisms of Delta 9-tetrahydrocannabinol behavioural sensitization. Eur. J. Neurosci. 17, 325-330.
51. Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., Belzung, C., Hen, R., 2003. Requirement of hippocampal neurogenesis for the behavioral effects of antidepressants. Science 301, 805-809. (Pubitemid 36962615)
52. Sinha, R., 2001. How does stress increase risk of drug abuse and relapse? Psychopharmacol. (Berl) 158, 343-359. (Pubitemid 33141310)
53. Solinas, M., Justinova, Z., Goldberg, S.R., Tanda, G., 2006. Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats. J. Neurochem. 98, 408-419. (Pubitemid 44133146)
54. Solinas, M., Yasar, S., Goldberg, S.R., 2007. Endocannabinoid system involvement in brain reward processes related to drug abuse. Pharmacol. Res. 56, 393-405.
55. Solinas, M., Goldberg, S.R., Piomelli, D., 2008. The endocannabinoid system in brain reward processes. Br. J. Pharmacol. 154, 369-383.
56. Solinas, M., Thiriet, N., El Rawas, R., Lardeux, V., Jaber, M., 2009. Environmental enrichment during early stages of life reduces the behavioral, neurochemical, and molecular effects of cocaine. Neuropsychopharmacology 34, 1102-1111.
57. Solinas, M., Thiriet, N., Chauvet, C., Jaber, M., 2010. Prevention and treatment of drug addiction by environmental enrichment. Prog. Neurobiol.
58. Stairs, D.J., Bardo, M.T., 2009. Neurobehavioral effects of environmental enrichment and drug abuse vulnerability. Pharmacol. Biochem. Behav. 92, 377-382.
59. Steiner, M.A., Wotjak, C.T., 2008. Role of the endocannabinoid system in regulation of the hypothalamic-pituitary-adrenocortical axis. Prog. Brain Res. 170, 397-432.
60. Stella, N., Schweitzer, P., Piomelli, D., 1997. A second endogenous cannabinoid that modulates long-term potentiation. Nature 388, 773-778. (Pubitemid 27375156)
61. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., Waku, K., 1995. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem. Biophys. Res. Commun. 215, 89-97.
62. Surget, A., Saxe, M., Leman, S., Ibarguen-Vargas, Y., Chalon, S., Griebel, G., Hen, R., Belzung, C., 2008. Drug-dependent requirement of hippocampal neurogenesis in a model of depression and of antidepressant reversal. Biol. Psychiatry 64, 293-301.
63. Tanda, G., Goldberg, S.R., 2003. Cannabinoids: reward, dependence, and underlying neurochemical mechanisms - a review of recent preclinical data. Psychopharmacol. (Berl) 169, 115-134.
64. Tasker, J.G., 2006. Rapid glucocorticoid actions in the hypothalamus as a mechanism of homeostatic integration. Obes. (Silver Spring) 14 (Suppl 5), 259S-265S.
65. Thiriet, N., Aunis, D., Zwiller, J., 2000. C-fos and egr-1 immediate-early gene induction by cocaine and cocaethylene in rat brain: a comparative study. Ann. NY Acad. Sci. 914, 46-57.
66. Thiriet, N., Jouvert, P., Gobaille, S., Solov'eva, O., Gough, B., Aunis, D., Ali, S., Zwiller, J., 2001. C-type natriuretic peptide (CNP) regulates cocaine-induced dopamine increase and immediate early gene expression in rat brain. Eur. J. Neurosci. 14, 1702-1708.
67. Thiriet, N., Amar, L., Toussay, X., Lardeux, V., Ladenheim, B., Becker, K.G., Cadet, J.L., Solinas, M., Jaber, M., 2008. Environmental enrichment during adolescence regulates gene expression in the striatum of mice. Brain Res. 1222, 31-41.
68. Thiriet, N., Gennequin, B., Lardeux, V., Chauvet, C., Decressac, M., Janet, T., Jaber, M., Solinas, M., 2010. Environmental enrichment does not reduce the rewarding and neurotoxic effects of methamphetamine. Neurotox. Res.
69. Thomas, E.A., Cravatt, B.F., Danielson, P.E., Gilula, N.B., Sutcliffe, J.G., 1997. Fatty acid amide hydrolase, the degradative enzyme for anandamide and oleamide, has selective distribution in neurons within the rat central nervous system. J. Neurosci. Res. 50, 1047-1052.
70. Tsou, K., Brown, S., Sanudo-Pena, M.C., Mackie, K., Walker, J.M., 1998a. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83, 393-411. (Pubitemid 28062631)
71. Tsou, K., Nogueron, M.I., Muthian, S., Sanudo-Pena, M.C., Hillard, C.J., Deutsch, D.G., Walker, J.M., 1998b. Fatty acid amide hydrolase is located preferentially in large neurons in the rat central nervous system as revealed by immunohistochemistry. Neurosci. Lett. 254, 137-140.
72. Ueda, N., Puffenbarger, R.A., Yamamoto, S., Deutsch, D.G., 2000. The fatty acid amide hydrolase (FAAH). Chem. Phys. Lipids 108, 107-121.
73. Valenti, M., Vigano, D., Casico, M.G., Rubino, T., Steardo, L., Parolaro, D., Di Marzo, V., 2004. Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain. Cell. Mol. Life Sci. 61, 945-950.
74. van Praag, H., Kempermann, G., Gage, F.H., 2000. Neural consequences of environmental enrichment. Nat. Rev. Neurosci. 1, 191-198.
75. Vigano, D., Valenti, M., Cascio, M.G., Di Marzo, V., Parolaro, D., Rubino, T., 2004. Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. Eur. J. Neurosci. 20, 1849-1857.
76. Viveros, M.P., Marco, E.M., Llorente, R., Lopez-Gallardo, M., 2007. Endocannabinoid system and synaptic plasticity: implications for emotional responses. Neural Plast. 2007, 52908.
77. Xu, Z., Hou, B., Gao, Y., He, F., Zhang, C., 2007. Effects of enriched environment on morphine-induced reward in mice. Exp. Neurol. 204, 714-719.
78. Zangen, A., Solinas, M., Ikemoto, S., Goldberg, S.R., Wise, R.A., 2006. Two brain sites for cannabinoid reward. J. Neurosci. 26, 4901-4907. (Pubitemid 44315331)